Clinical Trials Logo

Healthy clinical trials

View clinical trials related to Healthy.

Filter by:

NCT ID: NCT05503732 Recruiting - Healthy Clinical Trials

Effects of Energy Drinks on Sleep and Cardiovascular Health

Start date: September 1, 2022
Phase: N/A
Study type: Interventional

The purpose of this study is to learn about the change in quality of sleep, structural organization of sleep, and cardiovascular responses after consuming an energy drink compared to a placebo drink with no caffeine or stimulants.

NCT ID: NCT05501717 Recruiting - Healthy Clinical Trials

Safety, PK/PD, and Immunogenicity Study of SC ALXN2030 in Healthy Participants

Start date: August 16, 2022
Phase: Phase 1
Study type: Interventional

The primary purpose of this study is to assess the safety and tolerability of single ascending doses of ALXN2030 in healthy participants.

NCT ID: NCT05500300 Recruiting - Healthy Clinical Trials

Electrical Stimulation With Different Currents and Electromagnetic Fields

Start date: August 22, 2022
Phase: N/A
Study type: Interventional

Muscle strength is the amount of force generated by muscle contraction. It could be measured with an isometric dynamometer. This is a validated tool that could be used to measure Maximal Voluntary Isometric Contraction (MVIC) and Maximal Electrical Induced Contraction (MEIC). It is claimed that higher MEIC values will result in more force gained. If a current is more tolerated it will be easier to achieve better MEIC values. Tolerance to an electrical stimulation could be measured with the Visual Analogue Scale (VAS). A ratio between Normalized MEIC / VAS is often used, implying that the current is better with a higher ratio. Muscle fatigue is defined as a temporary loss or decrease in force-generating ability due to previous contractions. It is claimed that medium frequency neuromuscular electrical stimulation (NMES) generates more fatigue than low frequency currents. Aussie is a medium-frequency alternating current, sinusoidal waveform, 1 KHz carrier frequency. Neo-Russian is a medium-frequency current, rectangular biphasic symmetrical waveform, 2,5 KHz carrier frequency. Rectangular Biphasic symmetrical (RBS) waveform is a type of Low Pulsed Current (LPC), claimed to be better than classical Russian Current. Purpose: As it has been claimed that LPC is better in MEIC and tolerance, the aim of this study is to compare it with two newer medium frequency currents in terms of MEIC, tolerance and fatigue. Methods: Thirty male subjects, right leg dominant, will receive randomly the 3 types of electrical stimulation. Before that, the MVIC will be measured for data normalization. The MVIC and MEIC will be measured with an isometric dynamometer. In both measurements, subjects will be asked to perform three reps (5 sec work x 120 sec rest) and the best one will be used. Whenever the third one was the best, additional measurements will be taken until a decrease in torque will be obtained to determine the maximum. To apply Aussie electrical stimulation, an Aussie Sport (Ibramed) will be used. To apply Neo-Russian, a Neurodyn III (Ibramed) will be used. To apply RBS, a Genesy (Globus) will be used. The VAS will be used to assess tolerance to each treatment. One week later, the subjects will receive, randomly, a fatigue protocol that consists in 21 reps (5 sec work x 5 sec rest) of electrical stimulation with the three types of current. The data will be normalized with the MVIC and the reps equal or below 50 % of the first rep will be considered as a fatigue rep.

NCT ID: NCT05498207 Recruiting - Healthy Clinical Trials

Identification of Biomarkers for Stress Vulnerability and Resilience

Start date: August 23, 2022
Phase: N/A
Study type: Interventional

The purpose of this research study is to understand the biological mechanisms of stress vulnerability (being susceptible to stress) and stress resilience (being able to recover readily from stress), obtain biomarkers (a biological indicator) for stress resilience and to devise strategies for prevention and treatment of stress-related disorders.

NCT ID: NCT05492201 Recruiting - Healthy Clinical Trials

A Study of LY3873862 in Healthy Participants

Start date: August 11, 2022
Phase: Phase 1
Study type: Interventional

The main purpose of this study is to evaluate the safety and tolerability of LY3873862 when administered either in single or multiple doses in healthy participants. The study will also assess how fast LY3873862 gets into the blood stream and how long it takes the body to remove it. The study is open to healthy participants. The study will last up to approximately 58, 72, and 72 days for Part A, B, and C, respectively.

NCT ID: NCT05473208 Recruiting - Healthy Clinical Trials

Lumbar Assistive Exoskeletons in Caregiving

ExoCare
Start date: October 11, 2022
Phase: N/A
Study type: Interventional

A randomized control trial will be conducted, for evaluating the effectiveness of the implementation of a lower back assistive exoskeleton on the caregivers working in nursing homes.

NCT ID: NCT05472818 Recruiting - Healthy Clinical Trials

SV2A Density Cannabis Use Disorder

Start date: May 1, 2022
Phase: Early Phase 1
Study type: Interventional

The main purpose of this study is to determine whether hippocampal synaptic vesicle density estimated by hippocampal [11C]APP-311/[11C]UCB-J binding in individuals diagnosed with cannabis use disorder (CUDs) improves with at least 4 weeks of confirmed abstinence from cannabis, in comparison to healthy controls (HCs). Furthermore, any change in synaptic vesicle density will be placed in functional context by measuring verbal memory, which is sensitive to hippocampal function, before and after at least 4 weeks of confirmed abstinence. Finally, the relationship between hippocampal [11C]UCB-J binding in CUDs with measures of cannabis exposure (e.g., age of initiation, cumulative lifetime dose) will be explored.

NCT ID: NCT05472207 Recruiting - Healthy Clinical Trials

"Multifactorial Risk Stratification in Acute and Chronic Cardiovascular Disease"

riskINN
Start date: January 1, 2021
Phase:
Study type: Observational [Patient Registry]

The aim of this study is to develop risk prediction models for the early detection of high-risk patients with structural, rhythmological or inflammatory cardiovascular diseases.

NCT ID: NCT05462366 Recruiting - Healthy Clinical Trials

Omics Sequencing of Specimen Derived From Mother-Infant-Pairs

Start date: June 22, 2021
Phase:
Study type: Observational

The investigators aim to collect breast-milk and feces from the participants, and apply culture techniques as well as omics sequencing technology to probe into the microbial and metabolomic signature of the specimens.

NCT ID: NCT05457907 Recruiting - Healthy Clinical Trials

Ultrasound Therapy Effects to Modulate the Inflammatory Reflex

Start date: January 1, 2023
Phase: N/A
Study type: Interventional

This two treatment group study, including sham treatment, attempts to measure how ultrasound frequency, duration, intensity, and duty cycle impact its acute anti-inflammatory effect in healthy volunteers. It also attempts to contribute to the evidence regarding the comfort and safety of using therapeutic ultrasound. This pilot dose-finding study will be the basis for a larger Phase 2 trial in Rheumatoid Arthritis (RA) patients.